<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01808716</url>
  </required_header>
  <id_info>
    <org_study_id>CEP/UFRN 176/10</org_study_id>
    <nct_id>NCT01808716</nct_id>
  </id_info>
  <brief_title>Effect of Low-level Laser Therapy (808nm) on Marker of Muscle Damage</brief_title>
  <official_title>Effect of Low-level Laser Therapy (808nm) on Marker of Muscle Damage: Randomized Double-blind Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Sao Carlos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade Federal do Rio Grande do Norte</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal de Sao Carlos</source>
  <brief_summary>
    <textblock>
      The study hypothesis is a decreased muscle damage induced by exercises when low-level laser
      therapy is applied on body muscles before exercises.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study assessed males submitted to exercise to induce muscle damage. Creatine kinase
      levels in blood was quantified in order to identify the magnitude of muscle damage.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Creatine Kinase analysis in blood</measure>
    <time_frame>72 hours</time_frame>
    <description>Evaluation of Creatine Kinase (CK) levels in blood before, immediately after and 24h, 48h and 72h after protocol of exercise to induce muscle damage</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Low-level laser therapy (LLLT) on muscle damage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Effects of low-level laser therapy (LLLT)on muscle damage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-level laser therapy (LLLT) placebo on muscle damage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Effects of low-level laser therapy (LLLT) placebo on muscle damage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low-level laser therapy (808nm) and exercise</intervention_name>
    <description>Use of low-level laser therapy(LLLT)or placebo-LLLT applied on biceps brachii for muscle damage recovery</description>
    <arm_group_label>Low-level laser therapy (LLLT) on muscle damage</arm_group_label>
    <arm_group_label>Low-level laser therapy (LLLT) placebo on muscle damage</arm_group_label>
    <other_name>Laser device (808nm; 100mW; DMC®, Brazil)</other_name>
    <other_name>Low-level laser therapy</other_name>
    <other_name>Muscle damage</other_name>
    <other_name>Muscle recovery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy males,

          -  physically active,

          -  aged between 25-40 years.

        Exclusion Criteria:

          -  smoker, or

          -  under medicine as anti-inflammatory and/or any drug that could affect normal and
             physiological conditions and lesion in upper limbs.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wouber Hérickson de Brito Vieira, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidade Federal do Rio Grande do Norte</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal Univesity of Rio Grande do Norte</name>
      <address>
        <city>Natal</city>
        <state>Rio Grande do Norte</state>
        <zip>59072-970</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.etica.ufrn.br/</url>
    <description>Research Ethics Committee of the Federal University of Rio Grande do Norte</description>
  </link>
  <reference>
    <citation>Vieira WH, Ferraresi C, Perez SE, Baldissera V, Parizotto NA. Effects of low-level laser therapy (808 nm) on isokinetic muscle performance of young women submitted to endurance training: a randomized controlled clinical trial. Lasers Med Sci. 2012 Mar;27(2):497-504. doi: 10.1007/s10103-011-0984-0. Epub 2011 Aug 26.</citation>
    <PMID>21870127</PMID>
  </reference>
  <reference>
    <citation>Ferraresi C, de Brito Oliveira T, de Oliveira Zafalon L, de Menezes Reiff RB, Baldissera V, de Andrade Perez SE, Matheucci Júnior E, Parizotto NA. Effects of low level laser therapy (808 nm) on physical strength training in humans. Lasers Med Sci. 2011 May;26(3):349-58. doi: 10.1007/s10103-010-0855-0. Epub 2010 Nov 18.</citation>
    <PMID>21086010</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2013</study_first_submitted>
  <study_first_submitted_qc>March 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2013</study_first_posted>
  <last_update_submitted>March 7, 2013</last_update_submitted>
  <last_update_submitted_qc>March 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Sao Carlos</investigator_affiliation>
    <investigator_full_name>Cleber Ferraresi</investigator_full_name>
    <investigator_title>Cleber Ferraresi</investigator_title>
  </responsible_party>
  <keyword>low-level laser therapy</keyword>
  <keyword>muscle damage</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

